0001062993-23-009609.txt : 20230427 0001062993-23-009609.hdr.sgml : 20230427 20230427163702 ACCESSION NUMBER: 0001062993-23-009609 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230427 FILED AS OF DATE: 20230427 DATE AS OF CHANGE: 20230427 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Points Jeffrey S. CENTRAL INDEX KEY: 0001731414 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-52082 FILM NUMBER: 23857777 MAIL ADDRESS: STREET 1: C/O CARDIOVASCULAR SYSTEMS, INC. STREET 2: 1225 OLD HIGHWAY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardiovascular Systems Inc CENTRAL INDEX KEY: 0001180145 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411698056 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 BUSINESS PHONE: 651-259-1600 MAIL ADDRESS: STREET 1: 1225 OLD HWY 8 NW CITY: ST. PAUL STATE: MN ZIP: 55112 FORMER COMPANY: FORMER CONFORMED NAME: REPLIDYNE INC DATE OF NAME CHANGE: 20020813 4 1 form4.xml STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES X0407 4 2023-04-27 1 0001180145 Cardiovascular Systems Inc CSII 0001731414 Points Jeffrey S. 1225 OLD HIGHWAY 8 NW ST. PAUL MN 55112 0 1 0 0 Chief Financial Officer 0 Common Stock 2023-04-27 4 D 0 138957 20.00 D 34051 D Common Stock 2023-04-27 4 D 0 34051 20.00 D 0 D Pursuant to the Agreement and Plan of Merger by and among Cardiovascular Systems, Inc., a Delaware corporation, Abbott Laboratories, an Illinois corporation, and Cobra Acquisition Co., a Delaware corporation (the "Merger Agreement"), each share of unvested restricted stock became fully vested immediately prior to the effective time of the merger. Shares of restricted stock were then cancelled as of the effective time of the merger in exchange for the right to receive a cash payment equal to $20.00 multiplied by the number of restricted stock units, without interest and less any required withholding of taxes. Converted pursuant to the Merger Agreement into the right to receive $20.00 in cash per share, without interest and less any required withholding taxes. /s/ Andrew Nick as Attorney-in-Fact for Jeffrey S. Points pursuant to Power of Attorney previously filed. 2023-04-27